Home
>
National Drug Code (NDC)
>
Terazol 3
Terazol 3 - 50458-531-01 - (TERCONAZOLE)
Drug Information of Terazol 3
| Product NDC: | 50458-531 |
| Proprietary Name: | Terazol 3 |
| Non Proprietary Name: | TERCONAZOLE |
| Active Ingredient(s): | 80 mg/1 & nbsp; TERCONAZOLE |
| Administration Route(s): | VAGINAL |
| Dosage Form(s): | SUPPOSITORY |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Terazol 3
| Product NDC: | 50458-531 |
| Labeler Name: | Janssen Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019641 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19880524 |
Package Information of Terazol 3
| Package NDC: | 50458-531-01 |
| Package Description: | 1 DOSE PACK in 1 CARTON (50458-531-01) > 3 SUPPOSITORY in 1 DOSE PACK |
NDC Information of Terazol 3
| NDC Code | 50458-531-01 |
| Proprietary Name | Terazol 3 |
| Package Description | 1 DOSE PACK in 1 CARTON (50458-531-01) > 3 SUPPOSITORY in 1 DOSE PACK |
| Product NDC | 50458-531 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TERCONAZOLE |
| Dosage Form Name | SUPPOSITORY |
| Route Name | VAGINAL |
| Start Marketing Date | 19880524 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | TERCONAZOLE |
| Strength Number | 80 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |
